For YAP1-positive GC, those with positive VGLL4 had significantly worse survival than those with negative VGLL4, suggesting that a combination of YAP1 and VGLL4 showed superior efficacy for GC surveillance [25]. This evidence concerns the gene YAP1 and gastric cancer.